PuraPharm Corporation Limited
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through fi…
Drug Manufacturers - Specialty & Generic
HK, Tai Po [HQ]
Ratios
11 Records · Starting from 2013Margins, Growth Rates In %
| Ratio | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||
| Gross Margin | 64.04 | 63.36 | 64.51 | 65.08 | 66.92 | 61.02 | 57.13 | 61.26 | 63.96 | 58.16 | 52.81 | |
| Profit Margin | 7.67 | 9.41 | 6.01 | 6.00 | 0.32 | 2.79 | -32.66 | 5.27 | -18.48 | -26.83 | -26.07 | |
| Operating Margin | 10.97 | 14.17 | 9.74 | 7.54 | -0.49 | 1.24 | -8.80 | -0.81 | 2.67 | -14.40 | -12.68 | |
|
EPS Growth
|
- - | - - | -99.80 | -6.67 | -94.36 | 968.35 | -1,071.56 | 110.43 | -462.57 | 3.23 | 10.00 | |
| EPS HKD | - - | 7,454.00 | 15.00 | 14.00 | 0.79 | 8.44 | -82.00 | 8.55 | -31.00 | -30.00 | -27.00 | |
| Return on Assets (ROA) | 7.54 | 8.20 | 4.08 | 3.74 | 0.15 | 1.56 | -18.59 | 2.31 | -10.11 | -11.83 | -12.57 | |
| Return on Equity (ROE) | 35.96 | 25.40 | 6.06 | 7.08 | 0.34 | 3.70 | -62.76 | 6.20 | -30.35 | -46.54 | -69.23 | |
| Return on Invested Capital (ROIC) | 12.73 | 13.29 | 5.50 | 4.70 | -0.05 | 0.66 | -7.48 | -0.38 | 2.00 | -8.84 | -9.61 | |
| Solvency | ||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 54.06 | 43.47 | 17.99 | 30.35 | 42.35 | 39.92 | 40.83 | 35.63 | 42.53 | 46.96 | 47.76 | |
| Debt/Equity | 257.68 | 134.64 | 26.70 | 57.44 | 99.81 | 94.65 | 137.81 | 95.71 | 127.73 | 184.80 | 263.05 | |
| Debt/EBITDA | 314.65 | 208.44 | -180.60 | 93.21 | 2,106.39 | 989.30 | 8,139.57 | 930.23 | 659.57 | -2,501.06 | -12,618.62 | |
|
Debt/Capitalization
|
72.04 | 57.38 | 21.08 | 36.48 | 49.95 | 48.63 | 57.95 | 48.90 | 56.09 | 64.89 | 72.46 | |
| Long-Term Debt/Capitalization | 6.22 | - - | - - | - - | 9.00 | 20.85 | 28.41 | 25.92 | 18.64 | 15.86 | 34.61 | |
| Interest Debt per Share HKD | - - | 423.37 | 0.69 | 1.21 | 2.37 | 2.26 | 1.92 | 1.40 | 1.37 | 1.27 | 1.09 | |
| Debt Growth | - - | -2.92 | -31.34 | 108.12 | 109.93 | 0.08 | -1.27 | -3.22 | 1.50 | -5.41 | -15.58 | |
| Liquidity | ||||||||||||
| Current Ratio | 89.49 | 108.15 | 239.51 | 163.50 | 101.18 | 121.89 | 93.53 | 102.67 | 91.81 | 73.04 | 61.21 | |
| Quick Ratio | 65.19 | 76.34 | 191.72 | 122.02 | 57.22 | 78.69 | 60.51 | 70.54 | 61.78 | 44.36 | 30.46 | |
| Cash Ratio | 12.24 | 16.54 | 102.78 | 51.92 | 12.69 | 17.46 | 14.57 | 21.37 | 12.78 | 16.08 | 8.27 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||
| Inventory Turnover | 188.74 | 149.33 | 155.73 | 112.04 | 65.08 | 111.99 | 141.39 | 122.60 | 118.99 | 98.26 | 109.35 | |
| Receivables Turnover | 346.66 | 355.34 | 294.32 | 231.34 | 243.84 | 256.49 | 265.25 | 228.32 | 219.84 | 286.99 | 360.43 | |
| Payables Turnover | 412.03 | 301.35 | 441.49 | 252.30 | 174.44 | 208.77 | 166.66 | 146.30 | 169.00 | 135.95 | 131.18 | |
|
Asset Turnover
|
98.33 | 87.16 | 67.96 | 62.31 | 45.72 | 55.92 | 56.93 | 43.78 | 54.70 | 44.08 | 48.21 | |
| Fixed Turnover | 424.20 | 471.32 | 505.69 | 456.61 | 199.14 | 252.99 | 168.53 | 108.55 | 134.05 | 103.94 | 102.51 | |
| Coverage | ||||||||||||
| Interest Coverage | - - | 397.33 | 450.47 | 433.21 | -15.21 | 37.39 | -197.57 | -15.96 | 65.19 | -266.72 | -188.21 | |
| Asset Coverage | 100 | 100 | 400 | 200 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Cash Flow Coverage (CFGR) | 5.86 | 17.02 | -10.02 | -21.39 | -7.80 | 13.62 | 20.43 | 17.70 | -7.67 | 13.80 | 13.39 | |
| EBITDA Coverage | - - | 400 | 500 | 500 | 100 | 100 | - - | 100 | 200 | - - | - - | |
| Dividend Coverage | - - | - - | - - | -100 | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | - - | - - | 100 | - - | - - | |
| Market Prospects | ||||||||||||
| Dividend Yield | - - | - - | - - | 2.39 | 0.69 | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | - - | 2,060.57 | 3.56 | 3.85 | 0.27 | 4.26 | -68.09 | 12.58 | -38.22 | -23.80 | -30.17 | |
|
Price/Earnings (P/E)
|
- - | 0.0485 | 28.0822 | 25.9835 | 376.5484 | 23.4985 | -1.4686 | 7.9525 | -2.6168 | -4.2014 | -3.3144 | |
| Price/Earnings Growth (PEG) | - - | - - | -28.14 | -389.75 | -399.07 | 2.43 | 0.14 | -7.20 | 0.57 | 130.24 | 33.14 | |
|
Price/Book (P/B)
|
- - | 1.23 | 170.14 | 183.87 | 129.54 | 86.96 | 92.17 | 49.29 | 79.42 | 195.54 | 229.45 | |
| Price/Tangible Book (P/TB) | - - | 1.23 | 170.14 | 183.87 | 129.54 | 86.96 | 92.17 | 49.29 | 79.42 | 195.54 | 229.45 | |
| Price/Sales (P/S) | - - | 0.46 | 168.64 | 155.91 | 120.24 | 65.58 | 47.96 | 41.90 | 48.35 | 112.72 | 86.42 | |
|
Price/Cash Flow (P/CF)
|
- - | 5.38 | -6,357.70 | -1,496.89 | -1,663.78 | 674.72 | 327.42 | 290.92 | -810.95 | 767.02 | 651.41 | |
| Price/Free CF (P/FCF) | - - | 7.43 | -1,949.89 | -860.53 | -492.66 | 1,792.91 | 6,707.21 | 6,573.91 | -695.03 | 1,194.30 | 1,088.06 | |
| Price/Operating CF (P/OCF) | - - | 5.38 | -6,357.70 | -1,496.89 | -1,663.78 | 674.72 | 327.42 | 290.92 | -810.95 | 767.02 | 651.41 |